F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review and staff interviews, the facility failed to ensure a Resident's blood pressure was
consistently monitored as ordered. This affected one Resident (#22) of five reviewed for adequate
monitoring. The facility census was 28.
Residents Affected - Few
Findings include:
Medical record review revealed Resident #22 was admitted to the facility on [DATE] with diagnoses
including Alzheimer's Disease and essential primary hypertension (high blood pressure).
Review of Resident #22's physician orders dated 02/19/21 revealed an order for Diltiazem (for high blood
pressure) 120 milligrams (mg), every day. The order included to monitor the resident's blood pressure (BP)
daily for 14 days and report the findings to the nurse practitioner for review after two weeks.
Review of Resident #22's medication administration record (MAR) and treatment administration record
(TAR) for the period 02/19/21 through 03/05/21 revealed there was no evidence the resident's BP was
monitored on 02/20/21, 02/21/21, 02/22/21, 02/23/21, 02/26/21, 03/01/21, 03/02/21, 03/03/21, 03/04/21
and 03/05/21.
Interview on 04/13/21 at 2:25 P.M. with the Assistant Director of Nursing (ADON) #500 revealed it was
protocol for the vitals to be documented in the resident's MAR/TAR. The ADON verified there was no
evidence Resident #22's BP was monitored 10 of 14 times between 02/19/21 through 03/05/21.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
366031
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366031
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/15/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mill Manor Care Center
983 Exchange St
Vermilion, OH 44089
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review and staff interview, the facility failed to ensure ordered medications were
documented as administered. This affected one Resident (#4) of five reviewed for medication review. The
facility census was 28.
Findings include:
Medical record review revealed Resident #4 was admitted to the facility on [DATE] with diagnoses including
vascular dementia with behavioral disturbance, agitation, history of a stroke, weight loss, and hypertension
(high blood pressure).
Review Resident #4's physician orders and Medication Administration Record (MAR) revealed the
following:
1. Divalproex sodium sprinkles (anti-convulsant), 250 milligrams (mg) by mouth twice a day was ordered on
10/02/20. Review of the MAR revealed no evidence the medication was administered on 01/06/21,
01/07/21, 01/13/21, 02/10/21, 02/28/21, 03/08/21 for evening dose. There was no evidence the medication
was given in the morning on 02/15/21 and 03/31/21.
2. Melatonin (for sleep) 3 mg by mouth every evening was ordered on 04/03/19. Review of the MAR
revealed there was no evidence the medication was administered on 01/06/21, 01/07/21, 01/13/21,
02/10/21, 02/11/21, 02/28/21, and 03/18/21.
3. Memantine (for dementia) HCL 100 mg twice daily was ordered on 04/03/19. Review of the MAR
revealed no evidence the medication was administered on 01/06/21, 01/07/21, 01/13/21, 02/10/21,
02/28/21, 03/18/21, for the evening administration, and on 02/15/21 and 03/31/21 for the morning dose.
4. Quetiapine Fumarate (anti-psychotic), 50 mg was ordered on 02/19/20. Review of the MAR revealed no
evidence the medication was administered on 01/05/21, 01/06/21, 01/07/21, 01/13/21, 02/10/21 and
02/28/21.
Interview on 04/14/21 at 3:00 P.M. with the Director of Nursing (DON) and Assistant Director of Nursing
(ADON) verified there was no documented evidence the above medications were administered as ordered.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366031
If continuation sheet
Page 2 of 2